Advisor Group Holdings, Inc. Oramed Pharmaceuticals Inc. Call Options Transaction History
Advisor Group Holdings, Inc.
- $43.4 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ORMP
# of Institutions
61Shares Held
5.69MCall Options Held
8.3KPut Options Held
2.7K-
Murchinson Ltd. Toronto, A61.38MShares$3.56 Million0.36% of portfolio
-
Bml Capital Management, LLC Zionsville, IN844KShares$2.18 Million1.65% of portfolio
-
Boothbay Fund Management, LLC New York, NY690KShares$1.78 Million0.05% of portfolio
-
Morgan Jess S & CO Inc366KShares$945,3142.07% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA344KShares$888,6500.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $100M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...